8YT-15116-11662
4 vaccinations
7 coded responses
8 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 871 / NM
- Registered
- 2022-11-04
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-10-17
Dose 3 — Pfizer-BioNTech
-
2022-11-03
Dose 4 — Pfizer-BioNTech
-
2022-11-04
Registered in v-safe
-
2022-11-04
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sore throat, rhinorrhea, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-05
Survey response — days 1–6 daily, dose 4MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-06
Survey response — days 1–6 daily, dose 4MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Muscle or body achesFree text: Congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-07
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Rhinorrhoea — Feeling: FairFree text: Runny nose, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-11-08
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Discharge — Feeling: GoodFree text: Drainage, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-11-09
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Upper-airway cough syndrome — Feeling: GoodFree text: Post nasal drip, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-11-12
Survey response — day 7, dose 4MedDRA: Cough, Respiratory tract congestion, Upper-airway cough syndrome — Feeling: GoodFree text: Post nasal drip, mild congestion and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-11-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | No |
| 2 | 2021-01-11 | Pfizer-BioNTech | No |
| 3 | 2021-10-17 | Pfizer-BioNTech | No |
| 4 | 2022-11-03 | Pfizer-BioNTech | No |
Free text
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Sore throat, rhinorrhea, congestion
Systemic reaction (other): Congestion, runny nose
Systemic reaction (other): Congestion, runny nose
Systemic reaction (other): Runny nose, cough
Systemic reaction (other): Drainage, cough
Systemic reaction (other): Post nasal drip, cough
Release 12 — day 7, dose 4
Systemic reaction (other): Post nasal drip, mild congestion and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
| SRO | Discharge | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release